Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer and thrombosis.

Marcel Levi1

  • 1University of Amsterdam and Department of Medicine, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands. m.m.levi@amc.uva.nl

Clinical Advances in Hematology & Oncology : H&O
|November 1, 2005
PubMed
Summary

Cancer frequently causes thrombosis, a condition that can be the initial indicator of an undiagnosed malignancy. Risk factors include cancer type, metastasis, and chemotherapy, with various procoagulant states identified in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Broad-minded or highly specialised: Which physician provides the best care for acutely Ill medical patients?

European journal of internal medicine·2026
Same author

Artificial intelligence in diagnostics and medical decision making.

European journal of internal medicine·2026
Same author

Response to the comment by Gando on the updated definition and scoring of disseminated intravascular coagulation.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Laboratory and Medicine 2.1: Care for What You Wish for.

International journal of laboratory hematology·2026
Same author

Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Organ Dysfunction in Sepsis-associated Intravascular Coagulation.

Juntendo Iji zasshi = Juntendo medical journal·2024

Area of Science:

  • Oncology
  • Hematology
  • Pathophysiology

Background:

  • Cancer is often complicated by thrombosis, which can be the first presenting sign of an unrecognized malignancy.
  • Several risk factors contribute to cancer-associated thrombosis, including malignancy type, metastatic status, and chemotherapy use.
  • A procoagulant state is common in cancer patients, ranging from subtle lab abnormalities to disseminated intravascular coagulation.

Purpose of the Study:

  • To review the multifaceted relationship between cancer and thrombosis.
  • To elucidate the risk factors and pathogenetic mechanisms of cancer-associated coagulopathy.
  • To discuss specific thrombotic complications like chemotherapy-induced thrombotic microangiopathy.

Main Methods:

  • Literature review of existing studies on cancer-associated thrombosis.
  • Analysis of pathogenetic pathways involved in cancer coagulopathy.
  • Identification of risk factors and clinical manifestations of thrombosis in cancer patients.

Main Results:

  • Thrombosis is a common complication of cancer and can be its initial manifestation.
  • Malignancy type, metastatic disease, and chemotherapy are significant risk factors for thrombosis.
  • Cancer patients exhibit a spectrum of procoagulant states, including thrombotic microangiopathy related to treatments.

Conclusions:

  • Understanding the identified pathogenetic pathways is crucial for managing cancer-associated thrombosis.
  • Early recognition and management of thrombosis are vital in cancer care.
  • Further research into specific thrombotic entities like chemotherapy-induced thrombotic microangiopathy is warranted.

Related Experiment Videos